Cargando…
Emerging Role of Baricitinib in Dermatology Practice: All We Need to Know!
Baricitinib is a competitive inhibitor of the Janus Kinase family of non-receptor protein kinases, predominantly acting against JAK-1 and JAK-2 subtypes. By downregulating transcription of various pro-inflammatory cytokines, this drug has shown efficacy across various dermatoses. Approved for severe...
Autores principales: | Dogra, Sunil, Shah, Shikha, Sharma, Ayush, Chhabra, Seema, Narang, Tarun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115327/ https://www.ncbi.nlm.nih.gov/pubmed/37089829 http://dx.doi.org/10.4103/idoj.idoj_542_22 |
Ejemplares similares
-
Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022) -
Inflammasome Related Mediators and Their Association with Disease Determinants in Chronic Plaque Psoriasis
por: Chhabra, Seema, et al.
Publicado: (2021) -
An analysis of dermatological quality-of-life scores in relation to psychiatric morbidity in psoriasis
por: Singh, Shubh Mohan, et al.
Publicado: (2016) -
Neutrophil NETworking in ENL: Potential as a Putative Biomarker: Future Insights
por: Sahu, Smrity, et al.
Publicado: (2021) -
Coronavirus is Not the Only Corona We Know in Dermatology
por: Jha, Niharika
Publicado: (2021)